These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 38239990)
1. Pulmonary hypertension and insulin resistance: a mechanistic overview. Zanotto TM; Gonçalves AESS; Saad MJA Front Endocrinol (Lausanne); 2023; 14():1283233. PubMed ID: 38239990 [TBL] [Abstract][Full Text] [Related]
2. [Research progress in the correlation between insulin resistance and pulmonary arterial hypertension]. Ke R; Wu Y; Wang G; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):301-5. PubMed ID: 25736135 [TBL] [Abstract][Full Text] [Related]
3. Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man. Pugh ME; Hemnes AR Int J Clin Pract Suppl; 2010 Nov; 64(168):5-13. PubMed ID: 20939841 [TBL] [Abstract][Full Text] [Related]
4. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442 [TBL] [Abstract][Full Text] [Related]
5. The metabolic theory of pulmonary arterial hypertension. Paulin R; Michelakis ED Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764 [TBL] [Abstract][Full Text] [Related]
6. DNA Damage and Pulmonary Hypertension. Ranchoux B; Meloche J; Paulin R; Boucherat O; Provencher S; Bonnet S Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338373 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Hansmann G; Wagner RA; Schellong S; Perez VA; Urashima T; Wang L; Sheikh AY; Suen RS; Stewart DJ; Rabinovitch M Circulation; 2007 Mar; 115(10):1275-84. PubMed ID: 17339547 [TBL] [Abstract][Full Text] [Related]
12. Modern age pathology of pulmonary arterial hypertension. Stacher E; Graham BB; Hunt JM; Gandjeva A; Groshong SD; McLaughlin VV; Jessup M; Grizzle WE; Aldred MA; Cool CD; Tuder RM Am J Respir Crit Care Med; 2012 Aug; 186(3):261-72. PubMed ID: 22679007 [TBL] [Abstract][Full Text] [Related]
13. The Role of Bone Morphogenetic Protein Receptor Type 2 ( Devendran A; Kar S; Bailey R; Trivieri MG Cells; 2022 Nov; 11(23):. PubMed ID: 36497082 [TBL] [Abstract][Full Text] [Related]
14. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension. Bisserier M; Katz MG; Bueno-Beti C; Brojakowska A; Zhang S; Gubara S; Kohlbrenner E; Fazal S; Fargnoli A; Dorfmuller P; Humbert M; Hata A; Goukassian DA; Sassi Y; Hadri L Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502015 [TBL] [Abstract][Full Text] [Related]
15. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Orriols M; Gomez-Puerto MC; Ten Dijke P Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104 [TBL] [Abstract][Full Text] [Related]
16. microRNA and Pulmonary Hypertension. Boucherat O; Potus F; Bonnet S Adv Exp Med Biol; 2015; 888():237-52. PubMed ID: 26663186 [TBL] [Abstract][Full Text] [Related]
17. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556 [TBL] [Abstract][Full Text] [Related]
19. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient. Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ Cells; 2020 Jun; 9(6):. PubMed ID: 32521690 [No Abstract] [Full Text] [Related]